Specialty pharmaceuticals cost the nation approximately $60 billion in 2005. A small market in terms of patient population but the most explosive market in terms of growth. The challenge is to optimize utilization of these biopharmaceuticals to realize the true treatment potential without inhibiting the appropriate patient access. CSPN is in a much better position than traditional PBM services. Our members have expertise with the safety, short shelf life, special handling, immediate distribution, and clinical services to support patients with side effects and compliance with specialty medications. We are dedicated to providing an integrated solution aimed at helping lower drug costs, assisting healthcare providers and improving patient outcomes.
We offer a variety of services and years of industry expertise. See what we can do for you if you’re a …
